InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Blanchard Cheryl R, Présidente et Directrice Générale. Insider active across 2 companies, notably Anika Therapeutics, Inc.. In total, 5 reports have been recorded. Total volume traded: €99k. The latest transaction was disclosed on 26 April 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
024,576 shares0
Common Stock
SEC:0001171843-22-002980:0·
€98,7064,287 shares@ €23.02440.050% mcap54.5% of flow
Common Stock
SEC:0001171843-22-001833:0·
Ideal exit: 6 Dec 2022 (T+270)
014,420 shares0
Common Stock
SEC:0001171843-22-001809:0·
€82,4602,994 shares@ €27.54160.062% mcap100.0% of flow
Common Stock
SEC:0001171843-21-004397·
€82,4602,994 shares@ €27.54160.042% mcap45.5% of flow
Common Stock
SEC:0001171843-21-004397:0·
5 of 5 declarations
About Blanchard Cheryl R
Cheryl R. Blanchard is President and CEO of Anika Therapeutics, Inc. She leads the strategic and operational activities of the company, focusing on innovation and product development. Her leadership is essential in achieving Anika's growth objectives.
